In melanoma, exosomal miR-155 was found to trigger a proangiogenic switch in CAFs by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation (Zhou et al., 2018[70]). The gene discussed is SOCS1; the disease is melanoma.